Battling drug resistance.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016984:Enterococcus faecium; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D010080:Oxazoles / Q000627:therapeutic use*; D023303:Oxazolidinones; D013290:Streptococcal Infections / Q000188:drug therapy; D013297:Streptococcus pyogenes; D020713:Vancomycin Resistance; D014769:Virginiamycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D010080:Oxazoles; D023303:Oxazolidinones; D014769:Virginiamycin; C062940:quinupristin-dalfopristin